Causeway Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Causeway Capital Management's LLY Position: Q1 2019 in Review
Causeway Capital Management sold out of Eli Lilly (LLY) in Q1 2019, closing a stake of 81 shares — an estimated $9K sold.
Causeway Capital Management first reported a position in LLY in Q3 2014 and held it in 18 quarters. The position peaked at $287M in Q1 2018. 1,605 funds tracked by Wall St. Rank hold LLY as of Q1 2019.
- Causeway Capital Management reported no remaining Eli Lilly position as of Q1 2019 after selling out during the quarter.
- Causeway Capital Management sold 81 Eli Lilly shares in Q1 2019, an estimated $9K.
- Causeway Capital Management first reported a position in Eli Lilly in Q3 2014 and held it in 18 quarters.
- Causeway Capital Management's Eli Lilly position peaked at $287M in Q1 2018.
- 1,605 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.
Based on Causeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.